Neonatal and Pediatric Medicine
黑料网
Neonatal Drugs
Search results for
Neonatal Drugs
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Recommended Conferences
Vancouver, Canada
Toronto, Canada
Toronto, Canada
Citations : 303
Indexed In
- Google Scholar
- RefSeek
- Hamdard University
- EBSCO A-Z
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Neonatal Drugs
Maternal use of certain drugs during pregnancy can result in transient neonatal signs consistent with withdrawal or acute toxicity or cause sustained signs consistent with a lasting drug effect. In addition, hospitalized infants who are treated with opioids or benzodiazepines to provide analgesia or sedation may be at risk for manifesting signs of withdrawal. This statement updates information about the clinical presentation of infants exposed to intrauterine drugs and the therapeutic options for treatment of withdrawal and is expanded to include evidence-based approaches to the management of the hospitalized infant who requires weaning from analgesics or sedatives.
Related journals for Neonatal Drugs:
Surgery Annual, Pediatric Blood and Cancer, Current Opinion in Pediatrics, Pediatric Critical Care Medicine, Journal of Pediatric Gastroenterology and Nutrition, Journal of Pediatric Psychology
Neonatal Drugs
Expert PPTs
- Srinivasan Shanmugam
Lipid Based Oral Drug Delivery System (LBODDS)
PPT Version | PDF Version - Ioan Magyar
Introduction to Clinical Pharmacology
PPT Version | PDF Version
Speaker PPTs
- Barbara Klajnert-Maculewicz
Sugar-modified PPI dendrimers as carriers of anti-leukemia drugs
| PDF Version - Rinat Islamov
Pharmacokinetics (PK) of anti-tuberculosis drug (FS-1) on healthy volunteers: results from the phase I trial
| PDF Version - Almas Okassov
Chemical modification of anticancer Parasporins for decreasing of their toxicity
| PDF Version - Sevgi Gungor
Micelles as nanosized carriers for skin delivery of drugs
| PDF Version - Ru Band Lu
Anti-Inflammation and neuroprotective drugs benefit the treatment of heroin dependent patients
| PDF Version - Anita Nair
BCS-Based Biowaivers: Which Drugs are Eligible?
| PDF Version - Richard A. Kenley
Equilibrium binding interactions between lotrafilcon a soft contact lenses and the two prostaglandin anti-glaucoma drugs Bimatoprost and Tafluprost
| PDF Version - Elena Gavrilova
Application of drugs based on release-active antibodies as immunotherapy agents
| PDF Version - Jung-Joon Min
Bacteria-mediated expression of cargo drugs and reporter gene for cancer-specific theranostics
| PDF Version - Vladimir Torchilin
Stimuli-sensitive combination nanopreparations of siRNA and chemotherapeutic drugs to treat multidrug resistant cancer
| PDF Version - Grace London
Development of aptamer based HIV-1 entry inhibitor prophylactic drugs
| PDF Version - Aina Westrheim Ravna
Novel sildenafil analogues: possible drugs for increased sensitivity to chemotherapeutic agents
| PDF Version